JPRN-UMIN000018720招募中未知
Hepatitis B virus reactivation after allogeneic hematopoietic stem cell transplantation - HBV reactivation after allogeneic HSCT
The center for Liver Disease, Federation of National Public Service Personnel Mutual Aid Associations Hamanomachi Hospital0 个研究点目标入组 50 人开始时间: 2015年8月19日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Patients with HIV antibody positive 2. Patients with severe infectious disease (Patients whose general condition seemed to be poor like as septic shock ) 3. Patient who undergo hemodialysis 4. Patients with mental disorder which is object of treatment 5. Patients with poorly controlled DM, HT, or heart failure 6. Patients who are pregnant or nursing 7. Patients who are judged ineligible for this trial
研究者
相似试验
已完成
不适用
Investigation of hepatitis B virus reactivation after novel molecular targeted therapy with immunostimulatory effect (solid tumors)Solid cancer, Hepatitis BJPRN-UMIN000046853ational Institute for Medical Research and Development (AMED)321
已完成
不适用
Analysis for the reactivation of hepatitis B virus (HBV) in rheumatoid arthritis or psoriasis patients with past HBV infection treated with anti-tumor necrosis factor-alpha therapyrheumatoid arthritis or psoriasis patients with past hepatitis B virus infectionJPRN-UMIN000018017Department of general internal medicine, Kyushu-University hospital70
已完成
不适用
A retrospective study of HBV reactivation following chemotherapy for solid tumorsolid tumorJPRN-UMIN000017314Kobe City Medical Center General Hospital1,088
招募中
不适用
Risk assessment of hepatitis B virus reactivation in renal transplant patienthepatitis B virus renal transplant patientJPRN-UMIN000040545Department of Renal and Genitourinary surgery Hokkaido University Hospital500
进行中（未招募）
1 期
Prevention of re-onset of HBV infection in patients apparently cured affected by rheumatological diseases requiring finite duration treatments with drugs that impair the immune systems.EUCTR2015-000570-35-ITDIPARTIMENTO DI MEDICINA CLINICA E CHIRURGIA - UNIVERSITÀ DEGLI STUDI DI NAPOLI FEDERICO II40